Philips Respironics, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
- FDA recalls
- 9473 ongoing since 2021 (74 open in total)
At a glance
Market reach
- United States
- FDA recalls
What Philips Respironics, Inc. makes
Philips Respironics, Inc. manufactures an oximetry interface kit, designed to connect pulse oximetry sensors with monitoring systems for real-time blood oxygen level measurement.
The company’s products are classified under FDA Class II devices and are listed via 510(k) clearance. The manufacturer is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Oximetry Interface Kit Ref K111378
Regimes: 510(k) Registry: 510(k)
FDA recalls
FDA recall records list 94 recalls initiated by Philips Respironics, Inc., the earliest on 2016-01-18 and the most recent on 2026-03-02. By recorded status: 74 ongoing and 20 terminated. The reasons filed fall into these groups: labeling or instructions for use, software or firmware and electrical or power. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 0
- 2018 1
- 2019 13
- 2020 0
- 2021 18
- 2022 14
- 2023 11
- 2024 21
- 2025 7
- 2026 8
2026
- 2 Mar 2026 Z-1614-2026 Class I Ongoing Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Full distribution text
- 2 Mar 2026 Z-1615-2026 Class I Ongoing Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Full distribution text
- 2 Mar 2026 Z-1616-2026 Class I Ongoing Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Full distribution text
- 2 Mar 2026 Z-1617-2026 Class I Ongoing Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Full distribution text
- 2 Mar 2026 Z-1646-2026 Class I Ongoing In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.
Full distribution text
- 2 Mar 2026 Z-1647-2026 Class I Ongoing In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.
Full distribution text
- 2 Mar 2026 Z-1648-2026 Class I Ongoing In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.
Full distribution text
- 2 Mar 2026 Z-1649-2026 Class I Ongoing In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.
Full distribution text
- 2 Mar 2026 Z-1614-2026 Class I Ongoing Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
2025
- 7 Oct 2025 Z-0481-2026 Class II Ongoing Certain serial numbers of the SimplyGo Mini standard battery kit contain a defective chip which can lead the battery to either fail to charge or lose voltage output when in use in the device. If the fault occurs while the device is running on battery power, the SimplyGo Mini will shut down and stop providing oxygen to the user. This may happen at a temperature within the specified operating temperature range of the SimplyGo Mini.
- 30 Jun 2025 Z-2227-2025 Class I Ongoing Devices may possess a programming error resulting in an incorrect device configuration.
Full distribution text
Show the 25 most recent of 94 recalls
2025
- 30 Jun 2025 Z-2228-2025 Class I Ongoing Devices may possess a programming error resulting in an incorrect device configuration.
Full distribution text
- 30 Jun 2025 Z-2229-2025 Class I Ongoing Devices may possess a programming error resulting in an incorrect device configuration.
Full distribution text
- 9 May 2025 Z-2035-2025 Class I Ongoing This device does not indicate for use in patients with respiratory failure.
Full distribution text
- 9 May 2025 Z-2036-2025 Class I Ongoing This device does not indicate for use in patients with respiratory failure.
Full distribution text
- 9 May 2025 Z-2037-2025 Class I Ongoing This device does not indicate for use in patients with respiratory failure.
Full distribution text
- 30 Jun 2025 Z-2228-2025 Class I Ongoing Devices may possess a programming error resulting in an incorrect device configuration.
2024
- 7 Oct 2024 Z-0290-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Full distribution text
- 7 Oct 2024 Z-0291-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Full distribution text
- 7 Oct 2024 Z-0292-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Full distribution text
- 7 Oct 2024 Z-0293-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Full distribution text
- 7 Oct 2024 Z-0294-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Full distribution text
- 7 Oct 2024 Z-0295-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Full distribution text
- 7 Oct 2024 Z-0296-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Full distribution text
- 16 Jul 2024 Z-2942-2024 Class I Ongoing Firm has released a mandatory software update Version 1.05.10.00 and a User Manual addendum for affected ventilators. These updates resolve safety issues identified in earlier recalls.
Full distribution text
- 16 Jul 2024 Z-2943-2024 Class I Ongoing Firm has released a mandatory software update Version 1.05.10.00 and a User Manual addendum for affected ventilators. These updates resolve safety issues identified in earlier recalls.
Full distribution text
- 16 Jul 2024 Z-2944-2024 Class I Ongoing Firm has released a mandatory software update Version 1.05.10.00 and a User Manual addendum for affected ventilators. These updates resolve safety issues identified in earlier recalls.
Full distribution text
- 7 Oct 2024 Z-0290-2025 Class I Ongoing Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Frequently asked questions
How many devices does Philips Respironics, Inc. have in the registry?
The registry currently lists 2 devices for Philips Respironics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Philips Respironics, Inc.'s devices?
Among its 2 most recently registered devices, Philips Respironics, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Philips Respironics, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Philips Respironics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for Philips Respironics, Inc.?
FDA recall records list 94 recalls initiated by Philips Respironics, Inc., the most recent initiated on 2 Mar 2026. 74 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Philips Respironics, Inc. in the registry?
The most recently registered devices listed for Philips Respironics, Inc. include AF531 Oro-Nasal EE Leak 1 Face Mask; AF531 Oro-Nasal EE Leak 2 Face Mask and OXIMETRY INTERFACE KIT.